Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Keywords/Phrases:  cholangiocarcinoma
Results 1-25 of 50 for your search:
Start Over
Efficacy and Safety Study of PDT Using Photofrin in Unresectable Advanced Perihilar Cholangiocarcinoma (OPUS)
Status: Active
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: PIN-PHO1201, NCI-2014-02418, NCT02082522
A Phase II, Single Arm Study of BGJ398 in Patients With Advanced Cholangiocarcinoma
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CBGJ398X2204, NCI-2014-01310, 2013-005085-19, NCT02150967
A Phase 1 Study of BLU-554 in Patients With Hepatocellular Carcinoma and Cholangiocarcinoma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: BLU-554-1101, NCI-2015-01683, 2015-001662-26, NCT02508467
Hepatic Arterial Infusion in Treating Patients with Locally Advanced, Non-metastatic Cholangiocarcinoma
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 201111068, NCI-2011-03785, NCT01525069
Study of CX-4945 in Combination With Gemcitabine and Cisplatin for Frontline Treatment of Cholangiocarcinoma
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: S4-13-001, NCI-2015-00637, NCT02128282
RRx-001 in Second Line Treatment of Advanced Cholangiocarcinoma Prior to Readministration of First-Line Therapy
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: RRx001-27-01, NCI-2015-00944, NCT02452970
6,8-Bis(benzylthio)octanoic Acid in Treating Patients with Advanced or Metastatic Cholangiocarcinoma that Cannot Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 to 80
Trial IDs: CCCWFU 59212, NCI-2013-00063, NCT01766219
Radiation Therapy in Treating Patients with Hepatocellular Carcinoma, Cholangiocarcinoma, or Liver Metastasis Who Have Impaired Liver Function
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0052, NCI-2016-00006, NCT02626312
Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 and over
Trial IDs: MC1243, NCI-2013-01183, 12-007515, NCT01888302
A Study of LY2801653 in Advanced Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13008, NCI-2013-00662, I3O-MC-JSBA, NCT01285037
Fluorescent Visualization or DNA Analysis in Diagnosing Bile Duct Obstruction in Patients Undergoing Bile Duct Imaging
Status: Active
Phase: No phase specified
Type: Diagnostic
Age: 18 and older
Trial IDs: 201211068, NCI-2013-02250, 13-X110, Cytology 2013, NCT02000999
Study of Orally Administered AG-120 in Subjects With Advanced Solid Tumors, Including Glioma, With an IDH1 Mutation
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: AG120-C-002, NCI-2014-00868, NCT02073994
Gemcitabine Hydrochloride and Cisplatin with or without Radiation Therapy in Treating Patients with Localized Liver Cancer That Cannot Be Removed by Surgery
Status: Temporarily closed
Phase: Phase III
Type: Treatment
Age: 18 and over
Trial IDs: NRG-GI001, NCI-2014-00849, PNRG-GI001_A01PAMDREVW01, PNRG-GI001_A02PAMDREVW01, NCT02200042
Floxuridine, Dexamethasone, Gemcitabine Hydrochloride with or without Oxaliplatin in Treating Patients with Liver Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: 13-066, NCI-2013-01067, NCT01862315
Gemcitabine Hydrochloride, Cisplatin, and Nab-Paclitaxel in Treating Patients with Advanced or Metastatic Biliary Cancers
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2014-0524, NCI-2015-00578, NCT02392637
Gemcitabine Hydrochloride and Cisplatin before Surgery or Radiation Therapy in Treating Patients with Intrahepatic Bile Duct Cancer That Can or Cannot Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Treatment
Age: 18 and over
Trial IDs: 14-275, NCI-2014-02362, NCT02256982
Ramucirumab in Treating Patients with Advanced or Metastatic, Previously Treated Biliary Cancers That Cannot Be Removed by Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2015-0393, NCI-2015-01442, NCT02520141
Gemcitabine Hydrochloride, Floxuridine, and Dexamethasone after Surgery in Treating Patients with Liver Cancer That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Over 18
Trial IDs: 13-148, NCI-2013-01780, NCT01938729
Gemcitabine Hydrochloride, Cisplatin, and Yttrium Y 90-TARE in Treating Patients with Liver Cancer That Cannot Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 102254, NCI-2015-01276, MUSC 102254, NCT02512692
Combination Chemotherapy in Treating Patients With Previously Untreated Locally Advanced or Metastatic Gastrointestinal Malignancies
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 12-0033, NCI-2012-00585, 12-0033-AM010, NCT01643499
Regorafenib in Treating Patients With Advanced or Metastatic Biliary Tract Cancer Who Failed First-Line Chemotherapy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: UPCI 13-100, NCI-2014-01117, NCT02053376
Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
Status: Active
Phase: Phase IV
Type: Treatment
Age: 18 and over
Trial IDs: CDM00047339, NCI-2016-00348, E7059, NCT01774019
Tremelimumab with Transarterial Chemoembolization, Radiofrequency Ablation, Cryosurgery, or Stereotactic Body Radiation Therapy in Treating Patients with Advanced Liver or Biliary Tract Cancer
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 13-C-0120, NCI-2013-01557, 130120, P121113, NCT01853618
BGJ398 for Patients With Tumors With FGFR Genetic Alterations
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: CBGJ398XUS04, NCI-2014-01999, NCT02160041
Phase 1/2 Study of ARQ 087 in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations
Status: Active
Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ARQ 087-101, NCI-2013-00121, NCT01752920
Start Over